+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Targeted Therapies"

From
From
From
From
From
Gene Therapies For Cardiomyopathies - Pipeline Insight, 2024 - Product Thumbnail Image

Gene Therapies For Cardiomyopathies - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
From
From
From
From
Biosimulation Market Report and Forecast 2024-2032 - Product Thumbnail Image

Biosimulation Market Report and Forecast 2024-2032

  • Report
  • April 2024
  • 140 Pages
  • Global
From
ADME Toxicology Testing Market - Product Thumbnail Image

ADME Toxicology Testing Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
PEGylated Proteins Market - Product Thumbnail Image

PEGylated Proteins Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
Exosomes - Pipeline Insight, 2024 - Product Thumbnail Image

Exosomes - Pipeline Insight, 2024

  • Drug Pipelines
  • December 2024
  • 240 Pages
  • Global
From
From
Loading Indicator

The Targeted Therapies market within the context of Genomics is focused on the development of treatments that target specific genetic mutations or pathways. These therapies are designed to be more effective and have fewer side effects than traditional treatments. Genomics has enabled the development of personalized treatments that are tailored to the individual patient's genetic makeup. This has allowed for the development of drugs that target specific mutations or pathways, leading to more effective treatments. The Targeted Therapies market is a rapidly growing field, with many companies investing in research and development. Companies such as Gilead Sciences, Novartis, and AstraZeneca are leading the way in the development of targeted therapies. Other companies such as Merck, Pfizer, and Roche are also investing in the development of targeted therapies. Show Less Read more